Prevention of infectious complications subsequent to endoscopic treatment of the colon and rectum

Journal of Infection and Chemotherapy

Volumn 5, Issue 2, 1999, Pages 86-90

  Ishikawa, Hideki ^a   Akedo, Ikuko ^a   Minami, Takeshi ^b   Shinomura, Yasuhisa ^b   Tojo, Hiromasa ^b   Otani, Toru ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Antibiotics; Endoscopic treatment

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; KANAMYCIN; MAGNESIUM CITRATE; PHOSPHOLIPASE A2; TIMENTIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTESTINE LAVAGE; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; RECTOSCOPY; RISK ASSESSMENT; RISK FACTOR;

EID: 0033021653     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560050014     Document Type: Article

References (15)

1. Mitomi H, Igarashi M, Watanabe T, Naitou Y, Kobashi K, Katumata T, Saibenji K. A study on colonoscopic postpolypectomy complications and efficacy of new polypectomy technique to avoid complications. Progr Dig Endosc 1991;39:104-8.
2. Waye JD. The postpolypectomy coagulation syndrome. Gastrointest Endosc 1981;27:184-7.
3. Imanishi K, Tsutsui S, Fukusaki T, Uehara H, Iishi H, Nakaizumi A, et al. A new cleansing method in prevention for colonoscopy. Magcorol P whole gut lavage method. Kiso to Rinshou The Clinical Report 1990;24:7524-34.
4. Tojo H, Ono T, Okamoto M. Spleen phospholipases A2. Methods Enzymol 1991;197:390-9.
5. Berci G, Panish JF, Schapiro M, Corlin R. Complications of colonoscopy and polypectomy; report of the Southern California Society for Gastrointestinal Endoscopy. Gastroenterology 1974; 67:584-5.
6. Smith LE, Usn CM. Fiberoptic colonoscopy complications of colonoscopy and polypectomy. Dis Colon Rectum 1976;19:407-12.
7. Christie JP, Marrazzo J. "Mini-perforation" of the colon. Not all postpolypectomy perforations require laparotomy. Dis Colon Rectum 1991;34:132-5.
8. Brown GR. A new approach to colon preparation for barium enema. Univ Michigan Med Bull 1961;27:225-30.
9. Davis GR, Santa Ana CA, Morawski SG, Fordtran JS. Development of a lavage solution associated with minimal water and electrolyte absorption or secretion. Gastroenterology 1980;78: 991-5.
10. Imanishi K, Kondou H, Ishikawa H, Kiyohara T, Otani T. Clinical effect of MGU-5, oral gastrointestinal lavage solution in prevention for colonoscopy. Jpn Pharmacol Therapeutics 1989;17:3457-65.
11. Yasuda S, Noto T, Ikeda M, Kin T, Kubota M, Tajima T, et al. Whole-gut irrigation with polyethylene glycol electrolytes solution in preparation for colorectal operations. Jpn J Gastroenterol Surg 1988;21:2399-405.
12. Watanabe K, Sawa K, Yamaoka K, Sawamura H, Aoki M, Kobayashi T, Ueno K. Antibacterial activity of BRL28500 (Clavulanic acid-Ticarcillin) against anaerobes. Chemotherapy 1986;34:44-50.
13. Bithell TC. Thrombocytosis. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, editors. Wintrobe's clinical hematology. 9th ed. Philadelphia: Lea and Febiger, 1993;1390-1.
14. Vadas P, Pruzanski W. Role of secretory phospholipase A2 in the pathobiology of disease. Lab Invest 1986;55:391-404.
15. Minami T, Tojo H, Shinomura Y, Tarui S, Okamoto M. Elevated serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease. Its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut 1992;33:914-21.